We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,244.00
Bid: 1,234.00
Ask: 1,239.00
Change: 18.00 (1.47%)
Spread: 5.00 (0.405%)
Open: 1,226.00
High: 1,245.00
Low: 1,226.00
Prev. Close: 1,226.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement concerning non-cash accrual

23 Dec 2021 07:00

RNS Number : 5588W
Burford Capital Limited
23 December 2021
 

 

22 December 2021

 

Released via Form 6-K on December 22, 2021 and queued for release via RNS upon its reopening on December 23, 2021.

 

 

BURFORD CAPITAL STATEMENT CONCERNING NON-CASH ACCRUAL

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, today released the following statement.

 

On August 23, 2021, Burford announced that it would take a one-time, non-cash charge to earnings in 2021 to reflect the potential future expense associated with certain "carry" payments that may be payable to employees in connection with future investment performance.

 

Burford has also previously advised that it will move to reporting under US GAAP beginning with its financial statements for the current fiscal year. Under US GAAP, Burford has determined that the legal finance one-time, non-cash accrual announced in August will be applied to the 2019, 2020 and 2021 periods as opposed to being entirely recognized in 2021.

 

Upon further consideration of the relevant IFRS accounting treatment, we have also determined that the legal finance one-time, non-cash accrual should have been applied to 2019 and 2020 as well as 2021. There are no changes to the amount of the total charge and thus no changes to Burford's balance sheet as at June 30, 2021; this relates solely to the timing of recognition of the accruals for estimates of the liabilities.

 

The tables below present the impacted line items from the consolidated statement of comprehensive income and consolidated statement of financial position italicized for the periods impacted along with each of the impacted subtotals from those statements. The first table presents the data as originally reported, the second table presents how the non-cash accrual is recognized on both the originally reported and corrected bases, and the third table presents the data on the corrected basis. These tables are unaudited.

 

 

 

FY 2019

HY 2020

FY 2020

HY 2021

Selected financial highlights - As originally reported:

 $'000

 $'000

 $'000

 $'000

Operating expenses - general

(78,402)

(36,403)

(86,589)

(40,355)

Operating expenses - legal finance non-cash accrual

-

-

(44,856)

Operating expenses - asset recovery non-cash accrual

-

-

(34,083)

Operating expenses - case-related expenditures ineligible for inclusion in asset cost

(11,246)

(1,261)

(4,841)

(2,532)

Operating expenses - equity and listing related

(1,754)

(4,000)

(7,907)

(697)

Operating profit/(loss)

265,146

208,381

248,933

(39,822)

Profit/(loss) for the period before tax

225,524

188,615

208,635

(67,530)

Profit/(loss) for the period after tax

212,107

151,451

171,698

(67,080)

Total comprehensive income/(loss) for the period

194,582

184,887

161,492

(76,546)

 

 

 

 

 

Other liabilities

(51,430)

(41,526)

(66,099)

(125,640)

Total liabilities

(1,118,992)

(925,300)

(1,028,482)

(1,650,813)

Total net assets

1,532,992

1,720,800

1,699,812

1,598,711

 

 

 

 

 

Reserves attributable to owners

923,038

1,108,760

1,087,593

986,771

Total shareholders' equity

 1,532,992

1,720,800

1,699,812

1,598,711

 

 

 

 

 

 

FY 2019

HY 2020

FY 2020

HY 2021

Carry non-cash accrual recognition:

 $'000

 $'000

 $'000

 $'000

As originally reported

-

-

-

(37,545)

Corrected basis

(31,312)

(10,233)

(6,920)

687

        

 

FY 2019

HY 2020

FY 2020

HY 2021

Selected financial highlights - Corrected basis:

 $'000

 $'000

 $'000

 $'000

Operating expense - general

(78,402)

(36,403)

(86,589)

(40,355)

Operating expenses - legal finance non-cash accrual

(31,312)

(10,233)

(6,920)

(6,624)

Operating expenses - asset recovery non-cash accrual

-

-

-

(34,083)

Operating expenses - case-related expenditures ineligible for inclusion in asset cost

(11,246)

(1,261)

(4,841)

(2,532)

Operating expenses - equity and listing related

(1,754)

(4,000)

(7,907)

(697)

Operating profit/(loss)

233,834

198,148

242,013

(1,590)

Profit/(loss) for the period before tax

194,212

178,382

201,715

(29,298)

Profit/(loss) for the period after tax

180,795

141,218

164,778

(28,848)

Total comprehensive income/(loss) for the period

163,270

174,654

154,572

(38,314)

 

 

 

 

 

Other liabilities

(82,742)

(83,071)

(104,331)

(125,640)

Total liabilities

(1,150,304)

(966,845)

(1,066,714)

(1,650,813)

Total net assets

1,501,680

1,679,255

1,661,580

1,598,711

 

 

 

 

 

Reserves attributable to owners

891,726

1,067,215

1,049,361

986,771

Total shareholders' equity

1,501,680

1,679,255

1,661,580

1,598,711

 

FY 2019

HY 2020

FY 2020

HY 2021

Profit/(loss) per share - As originally reported:

 Cents

 Cents

 Cents

 Cents

Basic profit/(loss) per ordinary share

97

69

78

(31)

Profit/(loss) per fully diluted share

97

69

78

(31)

Basic comprehensive profit/(loss) per ordinary share

89

85

74

(35)

Comprehensive profit/(loss) per fully diluted share

89

84

73

(35)

 

FY 2019

HY 2020

FY 2020

H1 2021

Profit/(loss) per share - Corrected basis:

 Cents

 Cents

 Cents

 Cents

Basic profit/(loss) per ordinary share

83

65

75

(13)

Profit/(loss) per fully diluted share

82

64

75

(13)

Basic comprehensive profit/(loss) per ordinary share

75

80

71

(17)

Comprehensive profit/(loss) per fully diluted share

74

80

70

(17)

 

The Company will present three years of results reflecting these corrections in its annual report on Form 20-F expected to be released in March 2022. Given the error in reflecting the accrual, the following financial statements previously issued by the Company should no longer be relied upon to the extent inconsistent with the disclosure herein: (1) audited consolidated financial statements as of and for the years ended December 31, 2020 and 2019 and (2) unaudited condensed consolidated financial statements for the six-month periods ended June 30, 2021 and 2020. The Audit Committee of the Company's Board of Directors has taken this action which has been discussed with the Company's independent registered public accounting firm, Ernst & Young LLP.

 

Christopher Bogart, Burford's Chief Executive, commented: "This remains an entirely non-cash matter; the same non-cash expense is simply being spread across 2019 and 2020 instead of being entirely recognized in 2021. Indeed, the outcome of this will be to improve our reported performance in 2021, although there is no cash impact whatsoever."

 

For further information, please contact:

 

Burford Capital Limited

 

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

 

 

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Giles Rolls (NOMAD)

 

Charlie Farquhar / Jonathan Abbott (Joint Broker)

 

 

 

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

 

Tony White

 

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events, a change in our views or expectations or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDDBDDGDDDGBD
Date   Source Headline
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.